Search

The history of person-centred hearing care

In the World Report on Hearing, launched by the World Health Organization (WHO) on 3 March 2021, the use of person-centred care is highly recommended. In this article, we learn about the history of person-centred healthcare and hearing care. But...

Jameel Muzaffar, Anne Schilder and James O’Hara

In a follow-up to the interview with Anne Schilder back in 2016*, Jameel Muzaffar speaks to Anne and to James O’Hara about the current research landscape in ENT in the UK. *Banerjee A. In conversation with Professor Anne Schilder. ENT...

The role of artificial intelligence and applications in ENT surgery

AI is progressing apace. If you’re wondering how it might affect our working lives in ENT, read on for insights and a pilot study that show us what may be possible. The recent launch of ChatGPT, an open access artificial...

TRIBUTE: Ugo Fisch

EAONO collected in tributes from colleagues of Ugo Fisch who passed away on 12th December 2019 at the age of 88.  

Prednisolone and/or acyclovir for Bell’s palsy

Landmark Paper: Sullivan FM, Swan IRC, Donnan PT, et al. Early treatment with prednisolone or acyclovir in Bell’s Palsy. N Engl J Med 2007;357(16):1598-607. Facial nerve paralysis as a consequence of Bell’s palsy can result in devastating long-term effects on...

Lancet Commission on Hearing Loss

The Lancet Commission on Hearing Loss was convened in 2019, and its main report will be published in 2023. We learn more about it here. The Lancet Commission on Hearing Loss was convened in 2019, and was charged by Richard...

The lessons in setting up a community ENT service in the NHS

Sudeb Mandal, a GP with special interest in ENT, talks about the novel approach taken in the community to deliver ENT services in Kent in the UK. The Kent Community ENT service was born with the vision to bring together...

Listening differences in autistic individuals

In this article Erin Schafer, Lauren Mathews and Andrea Dunn outline the common auditory issues that autistic individuals face in comparison with their neurotypical peers and highlight the need to move beyond the traditional audiologic test battery when working with...

COOL therapy for cisplatin-induced hearing loss

Cisplatin is a commonly used cancer therapy, with nearly 50% of patients undergoing chemotherapy receiving cisplatin as part of their regimen [1]. Depending on the dose, incidence of hearing loss has been reported as 12-100% in adults, and 37-94% in...

Young ESPO’s thoughts about ESPO and the future of paediatric ORL

ESPO, and paediatric ORL in general, has a long tradition of encouraging our younger colleagues. This has led to innovative developments in clinical work, in research endeavours and in how paediatric ORL educational events are run. This article outlines some...

Being a doctor abroad – comparing the Greek healthcare system with the NHS

Healthcare systems and training programmes vary significantly across the world. By learning about other healthcare systems, we can identify blind spots in our own system and continue to improve training. Sofia Anastasiadou, an ENT Registrar in South West England, describes...